Cempra stock split

Melinta to Secure Public Listing With Cempra Merger - WSJ

Aug 09, 2017 · On a pro forma basis, and based upon the number of shares of Cempra common stock to be issued in the merger, current Cempra shareholders … CEMP Stock Quote - Melinta Therapeutics Inc - Bloomberg ... Stock analysis for Melinta Therapeutics Inc (CEMP) including stock price, stock chart, company news, key statistics, fundamentals and company profile. How Cempra’s shareholder vote on Melinta merger shook out ... Nov 03, 2017 · “Pursuant to the terms of the merger agreement, the proposal to increase the number of authorized shares of Cempra common stock is a condition to the closing of the merger,” Cempra stated. Melinta Therapeutics Announces One-for-Five Reverse Stock ...

On August 10, 2018, we effected a one for thirty five reverse stock split (the “ Reverse Stock to share amounts in this Annual Report, reflect the Reverse Stock Split. Argos Therapeutics Inc. Assembly Biosciences, Athersys Inc. Cempra Inc.

Cempra, Inc. (CEMP) Stock Message Board - InvestorsHub Jan 26, 2018 · Cempra, Inc., a clinical-stage biopharmaceutical company, engages in developing antibiotics for the treatment of bacterial infectious diseases. It focuses on developing antibiotics for treating respiratory tract, and skin and skin structure infections. Search - Nasdaq Stock Market | Stock Quotes & Stock ... Yes! I would like to receive Nasdaq communications related to Products, Industry News and Events. You can always change your preferences or unsubscribe and your contact information is covered by

With the combination of Melinta, the assets of Cempra and the assets of the IDB The per share prices below reflect a 5-for-1 reverse stock split executed on 

Jan 01, 2010 · Benzinga is a fast-growing, dynamic and innovative financial media outlet that empowers investors with high-quality, unique content. Technical Report on Pharma Stocks -- Novo Nordisk ... /PRNewswire/ -- Editor Note: For more information about this release, please scroll to bottom. Investor-Edge has initiated coverage on the following equities:

- MLNT - Stock Price Today - Zacks

Cempra (CEMP) Stock: Gaining Big On Positive Study Results ...

CEPM implements 1:5 reverse split in conjunction with

As merger closes, Cempra now trading as Melinta - Triangle ... Nov 07, 2017 · While Cempra’s shareholders failed to approve two proposals related to the merger, including “a proposal to increase the number of authorized shares of … CEMPRA INC : Stock Market News and Information ... Become a member for free. Sign up. Sign up Cempra (CEMP) Stock Soars on Solithromycin Results ... Shares of Cempra Inc. were trading up +6.60 or +28.83 percent to $29.49 per share in Monday's premarket.The company announced on January 4th that its lead product, solithromycin, had positive results in clinical trials. Cempra stock closed at $22.89 per share, down -0.62 or -2.64 percent in Friday's regular trading session. Analysts split on Cempra; price target range: $5 - 40 By ...

- MLNT - Stock Price Today - Zacks